Company Profile Boards & Staffs Memberships & Partners Academy of Journalism Careers Blog(EN)Contact Us

Our Journals Instruction for Authors Brieflands Policies Publish My Research Journal Management System Article Processing Charges Open Peer Review Publishing Services

Publish My Book

Hepatitis Monthly

Official Journal of Research Center for Gastroenterology and Liver Diseases

Current Issue Accepted Manuscripts All Issues In Press Articles Search

Journal Information Boards and committees Indexing and Listing Sources Journal Metrics Open Peer Review (OPR)Publication Ethics and Malpractice Statement Reviewer and AE Registration Form Support Contact Us

Authors Guide Submit Manuscript

Scopus by Title (Ref)

1. Predictors and risk factors of bile duct injury after transcatheter arterial chemoembolization for hepatocellular carcinoma

- Lu H. , et al.

2. Hepatocellular cancer in Iran

- Malekzadeh R. , et al.

3. Efficacy and safety of sorafenib combined with TACE in the treatment of advanced hepatocellular carcinoma: A meta-analysis

- Li D. , et al.

4. The consequences of transcatheter arterial chemoembolization in patients with liver cancer

- Esmaeili M. , et al.

5. The efficacy and complications of treatment modalities in patients with liver cancer: A review study

- Esmaeili M. , et al.

6. Systemic Management for Advanced Hepatocellular Carcinoma: A Review of the Molecular Pathways of Carcinogenesis, Current and Emerging Therapies, and Novel Treatment Strategies

- Saffo S. , et al.

7. Transarterial chemoembolization extends long-term survival in patients with unresectable hepatocellular carcinoma

- Kong J.Y. , et al.

8. Efficacy of Transcatheter Arterial Chemoembolization Followed by Sorafenib for Intermediate/Advanced Hepatocellular Carcinoma in Patients in Japan: A Retrospective Analysis

- Ohki T. , et al.